Escolar Documentos
Profissional Documentos
Cultura Documentos
gland
Hypothalamic Nuclei
preoptic nuclei temperature, heart rate, blood pressure, bladder control
10
Hypothalamic Nuclei
supraoptic nucleus antidiuretic hormone (vasopressin) paraventricular nucleus - antidiuretic hormone, oxytocin, water conservation ventromedial nucleus - satiety
11
Hypothalamic Nuclei
lateral hypothalamic nucleus /area hunger, thirst, blood pressure, heart rate suprachiasmatic nucleus - circadian rhythms
12
13
Cardiovascular Regulation
Lateral hypothalamic nucleus excitatory cardiovascular center Posterior hypothalamic nucleus and preoptic nucleus inhibitory cardiovascular center
14
Cardiovascular Control
Lateral hypothalamus increases arterial pressure, heart rate Preoptic area decreases arterial pressure, heart rate Both effects mediated through cardiovascular control centers in reticular regions of medulla and pons
15
16
Appetite
Hunger
Ventromedial hypothalamic nucleus satiety center Lateral hypothalamic area hunger center Glukose reseptor
Thirst
Stimuli: cell dehydration, body fluid volume changes
18
19
20
22
Appetite
Thirst Receptors: osmoreceptors, stretch receptors Roles of ADH, renin/angiotensin
23
ADH
Antidiuretic action: increases permeability of the collecting ducts to water V2 receptor Vasopressor action: - constricts vascular smooth muscle cells - V1 receptors
27
Thirst
28
30
32
Temperature
Anterior hypothalamus prevents temperature rise (panting, sweating, vasodilation) site of vascular temperature receptors Posterior hypothalamus prevents temperature loss glucose oxidation, vasoconstriction, piloerection, shivering Hypothalamic thermostat affected by aspirin, alcohol, interleukins
36
Temperature Regulation
37
Temperature Regulation
38
39
40
41
42
Emotional Behavior
Lesions in the ventromedial hypothalamic nuclei produce savage and vicious behavior, indicative of extreme rage. Stimulation of the dorsomedial nuclei also produces this reaction
43
44
Sexual Stages
Excitement (CNS, PSNS) Plateau Orgasm (SNS) Resolution
45
46
Immunotransmitters (cytokines etc.) produce changes in neuron firing Interleukin 1 acts on the hypothalamus to reset body thermostat and produce fever during infection Activated lymphocytes can produce various classical neurotransmitters
48
49
OXITOCIN
Function : contracts the myoepithelial cells of the alveoli in late pregnancy, uterine smooth muscle - (myometrium) becomes sensitive to oxytocin
Growth Hormone
Dr. Dini Sri Damayanti,MKes
What is Growth?
Growth is an increase in size of a tissue/organism due to - increase in cell size (hypertrophy) - increase in number of cells (hyperplasia) - increase in extracellular matrix around cells
hypertrophy
hyperplasia
Structure and Source of Growth Hormone GH is a large peptide hormone, with 191 amino acids GH is produced by somatotroph cells of the anterior pituitary
Regulation of GH Levels
GH is released from the pituitary in a pulsatile manner:
hormone level
time
GH levels are low during the day, but increase during sleep. There is an overall increase in GH levels during puberty.
JAK-2
Metabolic effect of GH
Increased rate of protein synthesis in all body cells Increased mobilization and use of fatty acids from adipose tissue for energy Decreased rate of glucose utilization throughout the body (i.e. enhances body protein, uses up fat stores and conserves CHO)
Direct Actions of GH
GH appears to act directly on cells to cause Lipolysis (breakdown of stored fat into free fatty acids) Glycogenolysis (breakdown of glycogen to form glucose)
Therefore, it makes sense that increased glucose levels will inhibit GH release.
IGF Receptors
IGFs bind to specific receptors (type-I IGF receptor and the insulin receptor) to stimulate growth. The type-I IGF receptor is similar to the insulin receptor, with intrinsic tyrosine kinase activity. Binding of IGFs to their receptors results in phosphorylation of insulin-responsive substrates (IRSs), which stimulate tissue growth and differentiation.
extracellular domains (ligand binding) plasma membrane tyrosine kinase domains growth & differentiation
phosphorylation of IRSs
IGF IGFBP
IGFBP Proteases
The activity of IGFBPs is also regulated by proteases which degrade IGFBPs. By regulating IGFBPs, these proteases may be important regulators of IGF bioactivity and bioavailability. Specific proteases have been identified for most IGFBPs.
IGFBP protease IGF
IGFBP
PSA
IGF
IGFBP3
Effects of Nutrition
There is also an interaction between genetic factors and nutrition. Adequate intake of nutrients (ie, vitamins and minerals) and calories is required to reach full growth potential, especially during childhood. Recall that arginine (an amino acid) stimulates GH release.
food
vitamins, minerals, calories from lipids, carbohydrates, and proteins
growth
GH
Hormone - Stress
Stress = any condition that threatens homeostasis GAS (General Adaptation Syndrome) is our bodies response to stress-causing factors Three phases to GAS
Alarm phase (immediate, fight or flight, directed by the sympathetic nervous system) Resistance phase (dominated by glucocorticoids) Exhaustion phase (breakdown of homeostatic regulation and failure of one or more organ systems)
Post-puberty: acromegaly
Some tissues still grow: cartilage in nose, hands, feet, ridges of eyebrow, chin, tongue Metabolic effects: constant increase in blood sugar, increased insulin type 2 diabetes. Can also increase muscle narrowing of arteries, heart attack
Pituitary Dwarfism
Due to lack of GH release from the pituitary, or lack of GH receptor expression (or other deficits.) Results in delayed growth and short stature (below 5 ft) in adult. Body development is proportional.
GH deficiency in children
GH deficiency isolated GH deficiency is characterized by
short stature, micropenis, increased fat, high-pitched voice.
diabetes and chronic renal failure represent secondary causes of GH receptor function. Children with these conditions typically exhibit features of acquired short stature with elevated GH and low IGFI levels. Circulating GH receptor antibodies may rarely cause peripheral GH insensitivity.
Laboratory investigation
GH deficiency is best assessed by examining the response to provocative stimuli including exercise, insulin-induced hypoglycemia and other pharmacologic tests which normally increase GH to<7g/L in children.
Reduced exercise capacity Cardiovascular risk factors: Impaired cardiac structure and function, abnormal lipid
profile, decreased fibrinolytic activity, atherosclerosis, omental abesity.
Laboratory investigation
Testing should be restricted to patients with the following predisposing factors: 1. Pituitary surgery 2. Pituitary or hypothalamic tumor or granulomas 3. Cranial irradiation 4. Radiological evidence of a pituitary lesion 5. Childhood requirement for GH replacement therapy
Treatment
In children: With growth hormone deficiency, the usual dose in the U.K is0.5to0.7 units\Kg body-weight, or 12to20 units\m2 bodysurface weekly. This weekly dose may be given by intramuscular injection in 3 divided doses or by subcutaneous injection, usually in6or7 divided doses. In adults: With growth hormone deficiency lower doses are recommended. A suggested initial dose is0.125 units\Kg weekly, divided into daily subcutaneous injection, and increased according to requirements up to a max. of 0.25 units\Kg per week.